| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/04/1996 | CA2208445A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds |
| 07/04/1996 | CA2208444A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
| 07/04/1996 | CA2208321A1 Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception |
| 07/04/1996 | CA2208291A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use |
| 07/04/1996 | CA2207772A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 07/04/1996 | CA2207653A1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents |
| 07/04/1996 | CA2207650A1 Use of a tachykinin antagonist and an opioid analgesic |
| 07/04/1996 | CA2207618A1 Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation |
| 07/04/1996 | CA2207548A1 Piperazine 2,5-dione derivatives as modulators of multi-drug resistance |
| 07/04/1996 | CA2207500A1 Piperazine 2,5 dione derivatives as modulators of multi-drug resistance |
| 07/04/1996 | CA2207268A1 6-¬triazolyl¬3-(trifluoromethyl)phenyl¦methyl¦-2-quinolinones and -quinolinethiones |
| 07/04/1996 | CA2206518A1 Production of cefotaxime and new sodium salts |
| 07/04/1996 | CA2205091A1 Chemical compounds |
| 07/04/1996 | CA2204741A1 High purity n-(4-[n,n-bis(2-iodoethyl)amino]phenoscycarbonyl)-l-glutamic acid |
| 07/04/1996 | CA2182946A1 Human phosphodiesterase type ivc, and its production and use |
| 07/03/1996 | EP0719791A2 Medicaments for the treatment of restenosis and arterial sclerosis |
| 07/03/1996 | EP0719787A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
| 07/03/1996 | EP0719783A2 Phosphorylated saccharide and method for producing the same |
| 07/03/1996 | EP0719782A1 Optically active benzothiepin derivative, its preparation and use |
| 07/03/1996 | EP0719778A1 Diamine salts of clavulanic acid |
| 07/03/1996 | EP0719777A2 N-oxotetrahydro-beta-carbolines |
| 07/03/1996 | EP0719776A1 8-Oxo-5,8-dihydro-6H-dibenzo(a,g) quinolizine-13-propanoic acid derivatives, their preparation and therapeutic use |
| 07/03/1996 | EP0719775A1 Substituted 4-phenyl thiazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 07/03/1996 | EP0719773A1 Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia |
| 07/03/1996 | EP0719772A1 Optically active imidazolidinone derivative and process for producing the same |
| 07/03/1996 | EP0719770A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 07/03/1996 | EP0719767A1 Succinamic acid compound, process for producing the same, and use thereof |
| 07/03/1996 | EP0719764A1 3-Phenylisoquinolin-1 (2H)-one derivatives as GABA receptor ligands |
| 07/03/1996 | EP0719763A1 4-(Quinolin-2-yl-methoxy)-phenyl acetic acid derivatives with antiatherosclerotic activity |
| 07/03/1996 | EP0719760A1 Naphthyloxyacetic acid derivatives and their use as PGW2 agonists and antagonists |
| 07/03/1996 | EP0719560A1 Antibordetella acellular vaccine |
| 07/03/1996 | EP0719559A1 Sodium hyaluronate viscous solutions for use as masking fluid in therapeutic photokeratectomy by means of excimer laser |
| 07/03/1996 | EP0719558A1 Ranolazine and related piperazines for use in the treatment of shock conditions |
| 07/03/1996 | EP0719557A1 Use of imidazopyridine derivatives for the manufacture of medicaments for the treatment of peripheral neuropathies |
| 07/03/1996 | EP0719556A2 Agent for treating diabetic keratopathy |
| 07/03/1996 | EP0719554A1 Chondroprotective flavonoids |
| 07/03/1996 | EP0719553A1 Pharmaceutical composition for topical administration to the eye for treating allergic conjunctivitis |
| 07/03/1996 | EP0719552A2 Pharmaceutical composition comprising a quinone derivative or a hydroquinone thereof for treating dermatitis |
| 07/03/1996 | EP0719551A2 Isolating aminoarginine and use to block nitric oxide formation in body |
| 07/03/1996 | EP0719550A2 A method of inhibiting endotoxin induced effects |
| 07/03/1996 | EP0719549A1 Soft gelatine pharmaceutical dosage form containing a translucent gel |
| 07/03/1996 | EP0719548A1 Gelling agent for polyethylene glycol |
| 07/03/1996 | EP0719546A1 LUV comprising saturated phospholipids and method of making the same |
| 07/03/1996 | EP0719540A1 Cosmetic or dermatological water-in-oil emulsion with high hydroxyacids content |
| 07/03/1996 | EP0719343A1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/03/1996 | EP0719278A1 Androstenone derivative |
| 07/03/1996 | EP0719277A1 Androstenones |
| 07/03/1996 | EP0719276A1 Orally active derivatives of 1,3,5(10)-estratriene |
| 07/03/1996 | EP0719275A1 Chemical compounds, their preparation and use |
| 07/03/1996 | EP0719274A1 Method for dosing therapeutic compounds |
| 07/03/1996 | EP0719273A1 Nucleotide analogs |
| 07/03/1996 | EP0719272A1 Pyrimidine derivatives for labeled binding partners |
| 07/03/1996 | EP0719271A1 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents |
| 07/03/1996 | EP0719268A1 K-252a DERIVATIVES WHICH ENHANCE NEUROTROPHIN-INDUCED ACTIVITY |
| 07/03/1996 | EP0719267A1 Second messenger cell signaling inhibitors |
| 07/03/1996 | EP0719266A1 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
| 07/03/1996 | EP0719264A1 Imidazolone and oxazolone derivatives as dopamine antagonists |
| 07/03/1996 | EP0719263A1 Heterocyclic carboxamide derivatives with antiarrhythmic activity |
| 07/03/1996 | EP0719262A1 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxide-3-carboxylic acid derivatives, their preparation and drugs containing same |
| 07/03/1996 | EP0719259A1 Substituted pyridines and pyrimidines, process for producing them and their use as pesticides and fungicides |
| 07/03/1996 | EP0719255A1 Substituted pyridines, process for producing them and their use as pesticides and fungicides |
| 07/03/1996 | EP0719253A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
| 07/03/1996 | EP0719252A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 07/03/1996 | EP0719251A1 Bicyclo (2.2.2) octane derivatives cholecystokinin and/or gastrin antagonists |
| 07/03/1996 | EP0719245A1 Novel compounds |
| 07/03/1996 | EP0719156A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
| 07/03/1996 | EP0719153A1 Inhibition of heparin-binding |
| 07/03/1996 | EP0719148A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 07/03/1996 | EP0719147A1 Gene therapy for solid tumors, papillomas and warts |
| 07/03/1996 | EP0719146A1 Novel method of progesterone delivery and affect thereof |
| 07/03/1996 | EP0719145A1 Nitric oxide donor composition and method for treatment of anal disorders |
| 07/03/1996 | EP0719144A1 Trans platinum(iv) complexes |
| 07/03/1996 | EP0719143A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 07/03/1996 | EP0719142A1 Pharmaceutical composition of hiv-protease inhibitors |
| 07/03/1996 | EP0719141A1 Novel use of dexmedetomidine |
| 07/03/1996 | EP0719140A1 Use of thiazolidinediones to prevent or delay onset of niddm |
| 07/03/1996 | EP0719139A1 Use of centrally active alphaagonists for inhibing postraumatic metabolic stress |
| 07/03/1996 | EP0719138A1 Iontophoretic delivery of an antimigraine drug |
| 07/03/1996 | EP0719137A1 Viscous surfactant emulsion compositions |
| 07/03/1996 | EP0719131A1 Oral compositions containing stannous compounds |
| 07/03/1996 | EP0719097A1 Novel dietetic phospholipid compositions and use thereof as a dietary supplement |
| 07/03/1996 | EP0669836B1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/03/1996 | EP0653911A4 Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen. |
| 07/03/1996 | EP0597107B1 Lignan analog, production thereof, and hypolipidemic drug |
| 07/03/1996 | CN1125947A Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 07/03/1996 | CN1125946A Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/03/1996 | CN1125945A Positive inotropic and lusitropic pyrroloquinolinone derivatives |
| 07/03/1996 | CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 07/03/1996 | CN1125943A Bis-imide polycyclic and heterocyclic chromophores useful as tumoricidals |
| 07/03/1996 | CN1125942A Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors |
| 07/03/1996 | CN1125941A Novel vitamin D analogues |
| 07/03/1996 | CN1125938A Bicyclic amide derivatives and their use as muscle relaxants |
| 07/03/1996 | CN1125725A First-kind "Haikelin" alkali derivant and its usage |
| 07/03/1996 | CN1125722A Ortho-substituted benzoic acid derivatives |
| 07/03/1996 | CN1125717A Cyclohexadiene derivatives |
| 07/03/1996 | CN1125714A Process for preparing new derivatives of 2,2-dinethyl cyclopropane carboxylic acid |
| 07/03/1996 | CN1125575A Adhesion receptor antagonists |
| 07/03/1996 | CN1125574A Enteric-soluble glutamine |
| 07/03/1996 | CN1125572A Manufacture method of "Luotongding"pain-killing tablet |
| 07/03/1996 | CN1032210C Process for preparing substituted thienopyrans as antihypertensive agents |